Susan Hasty, Publisher
Table of Contents . . . April 7th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Medical Device Business Week | Other Publications
AVI BioPharma, Inc. - Neugene maker reports quarterly loss of $0.10 per share
Alfacell Corporation - Savadelis named chief financial officer at pharmaceutical firm
American Oriental Bioengineering - Bioengineering firm expects record revenue growth, income for 2003
Aspreva Pharmaceuticals Corp. - Autoimmune disease drug maker completes raises $57 million
Avitar, Inc. - Diagnostics company announces second closing of private placement
BioRexis Pharmaceutical Corp. - Biopharmaceutical firm completes $30M series B financing
Business & Finance - Scripps Research Institute plans Florida research hospital
Chronogen, Inc. - New management appointments named at drug discovery firm
Columbia Laboratories, Inc. - Women's health pharmaceutical firm reports loss of $0.20 per share
CombinatoRx, Inc. - Biopharmaceutical firm raises $30M in third venture capital round
Corixa Corp. - Immunotherapeutics firm reports quarterly loss of $0.31 per share
Cutting Edge Information - Pharmaceutical companies spend over $900M on cholesterol drugs, study shows
Cutting Edge Information - Report suggests solution to pharmaceutical industry productivity decline
Cypress Bioscience, Inc. - Biotech company approved for listing on Nasdaq
Cytogen Corporation - Oncology company reports record product revenues
Psychiatric Solutions, Inc. - Psychiatric Solutions reports 181% fourth quarter revenue increase
AEterna Laboratories, Inc. - Company expands pipeline to include obesity, oncology therapies
Acacia Research Corporation - $5.9M contract awarded for development of biowarfare technology
Academy of Allergy, Asthma and Immunology - Study: Inhaled steroid therapy does not reduce fetal growth
Agfa-Gevaert Group - Tips will help streamline cardiology workflow
Alexion Pharmaceuticals, Inc. - Pexelizumab mortality benefit reported from multiple trials
Allos Therapeutics, Inc. - Oncology company files shelf registration statement
Alnylam Pharmaceuticals, Inc. - Isis Pharmaceuticals enters RNAi alliance
Ambit Biosciences - Biosciences firm adds members to scientific advisory board
American Pharmaceutical Partners - NDA filed with FDA for nanoparticle-based Abraxane
Amgen, Inc. - FDA approves Sensipar for the treatment of secondary hyperparathyroidism
Anlyan Center for Medical Research & Education - Lactating mammary glands respond to changes in extracellular calcium levels
Annamalai University - Kinins may help mediate hypotensive effects of taurine
Array BioPharma, Inc. - ARRY-142886 cleared to advance into human clinical trials
Aspen Education Group - Therapeutic boarding schools opened for overweight, obese youths
AstraZeneca - Preoperative treatment with anastrozole reduces need for extensive surgery
AstraZeneca - STELLAR data presented at meeting
Aventis Bulk S.p.A. - Complete genome sequence of Saccharopolyspora erythraea reported
Avian Influenza - Chinese delegation visits Delaware to discuss avian influenza
Azienda Ospedaliera di Padova - Antiretroviral therapy does not prevent HPV-induced genital lesions
Bayer Pharmaceuticals Corporation - Avelox shows clinical success for acute exacerbations of chronic bronchitis
Baylor College of Medicine - Radiation effective for some prostate patients with recurrent cancer
Baylor College of Medicine - Tumor suppressor genes predict bladder cancer future
Biochema Schwaben - International Specialty Products acquires biocide maker
Biomira, Inc. - Phase II colorectal vaccine trial results updated
Boehringer Ingelheim - COPD outcomes study completes patient recruitment
Boehringer Ingelheim Pharmaceuticals, Inc. - Flomax improves chronic prostatitis/chronic pelvic pain syndrome symptoms
Bovine Spongiform Encephalopathy - Funding pending for Canadian cattle industry reeling from mad cow scare
Breast Cancer - Breast cancer foundation honors four leaders
Breast Cancer - MEP calls for European strategy in the fight against breast cancer
Breast Cancer - Older people lose out all around in breast cancer treatment and care
Breast Cancer - South African government criticized for funding arms but not screening programs
Breast Cancer - Study highlights importance of diet in disease prevention
Breast Cancer - Survival rates same for conservation treatment or mastectomy for recurrent DCIS
Breast Cancer - Younger survivors suffer more long-term after effects
Business & Finance - Berlin, Vermont, hospital re-submits expansion plan to state
Business & Finance - Deal withdrawn for North Carolina bankrupt hospital
Business & Finance - Vista Medical Technologies receives Nasdaq notification
Business Update - Health insurer president has $2.8 million compensation package
CHRU, Clermont-Ferrand - Downregulated BRCA1 in melanoma modifies its metastatic potential
CHU Rangueil - Real-time PCR can provide rapid, accurate diagnosis
CNRS-Ecole Normale Superieure de Lyon - Cell-penetrating, Rev-binding peptides can protect against HIV
California Institute of Technology - GyrB distinguishes members of Bacillus anthracis-cereus-thuringiensis group
California Pacific Medical Center - Impact of HCV coinfection on risk of HAART-induced liver damage reviewed
CardioTech International, Inc. - Alliance partners to accelerate development of drug-eluting stent
Case Western Reserve University - Nephrogenic fibrosing dermopathy linked to dysregulated matrix remodeling
Cedars Sinai Medical Center - Male carriers of germline mutations in BRCA2 are at increased risk for cancer
Cellomics, Inc. - New high content biology platform launched for basic science research
Celltech Americas - Study demonstrates Metadate CD has greater effect than Concerta
Celsion Corp. - Milestone payments received, first patients treated with Prolieve
Central Food Tech. Research Institute, Karnataka - Cleavage of precursor enzyme causes amylase secretion by Aspergillus
Chiba University - No link found between human G-protein beta 3 subunit variant and overweight
Cima Labs Inc. - Orally disintegrating drug receives FDA approval for schizophrenia
Columbia Laboratories, Inc. - UK approval granted for Striant SR
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.